C57BL/6N-Tg(Vav1-STAT5B*N642H)726Biat/Biat

Status

Available to order

EMMA IDEM:12475
International strain nameC57BL/6N-Tg(Vav1-STAT5B*N642H)726Biat/Biat
Alternative nameB6N-Tg(STAT5BN/H)726Biat
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Vav1-STAT5B*N642H)726Biat
Gene/Transgene symbolTg(Vav1-STAT5B*N642H)726Biat

Information from provider

ProviderRichard Moriggl
Provider affiliationDepartment for Biomedical Sciences, University of Veterinary Medicine, Vienna (Vetmeduni Vienna)
Genetic informationTransgenic mice were generated and bred on a C57BL/6NCrl background. We used the Vav1-hematopoietic vector Vav1-hCD4 (HS21/45) to generate several transgenic mouse lines expressing hSTAT5B and hSTAT5BN642H in the hematopoietic system and selected the lines B6N-Tg(STAT5B)731Biat (EMMA ID EM:12476) and B6N-Tg(STAT5BN/H)726Biat (this one; EMMA ID EM:12475), respectively, for further experiments. The hSTAT5BN642H construct was generated using overlapping PCR technology.
Phenotypic informationHomozygous:
Unknown; homozygous animals were not produced.

Heterozygous:
hSTAT5BN642H mice develop an aggressive CD8+ T cell lymphoma at the age of 6-12 weeks. This goes in line with a massive expansion of spleen and lymphonodes, as well as organ infiltrations. For further details see Pham HTT et al., 2018. The heterozygous B6N Tg(STAT5B)731Biat line (EMMA ID EM:12476) exhibits no obvious phenotype and is used as an experimental control.
Breeding historyLess than 10 generations of backcross to C57BL/6N.
References
  • STAT5BN642H is a driver mutation for T cell neoplasia.;Pham Ha Thi Thanh, Maurer Barbara, Prchal-Murphy Michaela, Grausenburger Reinhard, Grundschober Eva, Javaheri Tahereh, Nivarthi Harini, Boersma Auke, Kolbe Thomas, Elabd Mohamed, Halbritter Florian, Pencik Jan, Kazemi Zahra, Grebien Florian, Hengstschläger Markus, Kenner Lukas, Kubicek Stefan, Farlik Matthias, Bock Christoph, Valent Peter, Müller Mathias, Rülicke Thomas, Sexl Veronika, Moriggl Richard, ;2018;The Journal of clinical investigation;128;387-401; 29200404
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivingheterozygous C57BL/6N

Disease and phenotype information

MGI allele-associated human disease models

Literature references

  • STAT5BN642H is a driver mutation for T cell neoplasia.;Pham Ha Thi Thanh, Maurer Barbara, Prchal-Murphy Michaela, Grausenburger Reinhard, Grundschober Eva, Javaheri Tahereh, Nivarthi Harini, Boersma Auke, Kolbe Thomas, Elabd Mohamed, Halbritter Florian, Pencik Jan, Kazemi Zahra, Grebien Florian, Hengstschläger Markus, Kenner Lukas, Kubicek Stefan, Farlik Matthias, Bock Christoph, Valent Peter, Müller Mathias, Rülicke Thomas, Sexl Veronika, Moriggl Richard, ;2018;The Journal of clinical investigation;128;387-401; 29200404

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).